Boufassa F - Search Results

1

MHC-driven HIV-1 control on the long run is not systematically determined at early times post-HIV-1 infection.

Antoni G, Guergnon J, Meaudre C, Samri A, Boufassa F, Goujard C, Lambotte O, Autran B, Rouzioux C, Costagliola D, Meyer L, Theodorou I. Antoni G, et al. Among authors: boufassa f. AIDS. 2013 Jul 17;27(11):1707-16. doi: 10.1097/QAD.0b013e328360a4bd. AIDS. 2013. PMID: 23462218

2

[Multicenter French cohort of adults with HIV infection. Description and course after 4 years of follow-up. SEROCO].

Bucquet D, Deveau C, Belanger F, Boufassa F, Desmoulins C, Jadand C, Carré N, Leibovici D, Vildé JL, Rouzioux C, et al. Bucquet D, et al. Among authors: boufassa f. Presse Med. 1994 Sep 17;23(27):1247-51. Presse Med. 1994. PMID: 7971858 French.

3

Effect of age and exposure group on the onset of AIDS in heterosexual and homosexual HIV-infected patients. SEROCO Study Group.

Carré N, Deveau C, Belanger F, Boufassa F, Persoz A, Jadand C, Rouzioux C, Delfraissy JF, Bucquet D. Carré N, et al. Among authors: boufassa f. AIDS. 1994 Jun;8(6):797-802. doi: 10.1097/00002030-199406000-00012. AIDS. 1994. PMID: 8086139

4

The use of auxiliary events to improve the analysis of survival for HIV-infected patients: application to the French Prospective Multicenter Cohort (SEROCO).

Flandre P, Boufassa F, Gerard L, Carré N, Persoz A, Meyer L. Flandre P, et al. Among authors: boufassa f. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Jun 1;12(2):174-81. doi: 10.1097/00042560-199606010-00011. J Acquir Immune Defic Syndr Hum Retrovirol. 1996. PMID: 8680889

5

High risk of HIV disease progression after infection through a sexual partner with AIDS.

Carré N, Meyer L, Boufassa F, Deveau C, Persoz A, Rouzioux C, Vildé JL. Carré N, et al. Among authors: boufassa f. AIDS. 1996 Jan;10(1):77-80. doi: 10.1097/00002030-199601000-00011. AIDS. 1996. PMID: 8924255

6

HEMOCO: a French prospective study of hemophiliacs infected by human immunodeficiency virus type 1 (HIV-1).

Boufassa F, Carré N, Deveau C, Sultan Y, Gazengel C, Blanc A, Peynet J, Ramirez D, Meyer L. Boufassa F, et al. Hematol Cell Ther. 1996 Apr;38(2):193-8. doi: 10.1007/s00282-996-0193-7. Hematol Cell Ther. 1996. PMID: 8932002

7

Predictive value of viral load and other markers for progression to clinical AIDS after CD4+ cell count falls below 200/microL. SEROCO & HEMOCO Study Group.

Carré N, Boufassa F, Hubert JB, Chavance M, Rouzioux C, Goujard C, Laurian Y, Meyer L. Carré N, et al. Among authors: boufassa f. Int J Epidemiol. 1998 Oct;27(5):897-903. doi: 10.1093/ije/27.5.897. Int J Epidemiol. 1998. PMID: 9839750

8

Do gender differences in CD4 cell counts matter?

Prins M, Robertson JR, Brettle RP, Aguado IH, Broers B, Boufassa F, Goldberg DJ, Zangerle R, Coutinho RA, van den Hoek A. Prins M, et al. Among authors: boufassa f. AIDS. 1999 Dec 3;13(17):2361-4. doi: 10.1097/00002030-199912030-00007. AIDS. 1999. PMID: 10597777

9

Sexual behavior changes and protease inhibitor therapy. SEROCO Study Group.

Miller M, Meyer L, Boufassa F, Persoz A, Sarr A, Robain M, Spira A. Miller M, et al. Among authors: boufassa f. AIDS. 2000 Mar 10;14(4):F33-9. doi: 10.1097/00002030-200003100-00001. AIDS. 2000. PMID: 10770530

10

Is cytomegalovirus infection a co-factor in HIV-1 disease progression?

Robain M, Boufassa F, Hubert JB, Dussaix E, Sadeg K, Meyer L. Robain M, et al. Among authors: boufassa f. Epidemiol Infect. 2000 Oct;125(2):415-20. doi: 10.1017/s0950268899004549. Epidemiol Infect. 2000. PMID: 11117966 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

161 results

Search Page

Filters